Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclerosis”

5,245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,245 results

Not applicableStudy completedNCT03887507
What this trial is testing

Vojta Therapy in Multiple Sclerosis.

Who this might be right for
Multiple SclerosisPhysical Therapy
NUMEN Foundation 21
Not applicableStudy completedNCT06019611
What this trial is testing

Epidural Stimulation in Multiple Sclerosis

Who this might be right for
Multiple SclerosisDemyelinating DisorderAutoimmune Diseases
Kristin Zhao, PhD 2
Testing effectiveness (Phase 2)Looking for participantsNCT07002034
What this trial is testing

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Who this might be right for
Adjustment Disorder
Reunion Neuroscience Inc 100
Not applicableStudy completedNCT05029206
What this trial is testing

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Uppsala University 174
Large-scale testing (Phase 3)Ended earlyNCT01252355
What this trial is testing

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Who this might be right for
Multiple Sclerosis Relapse
Sanofi 534
Post-approval studies (Phase 4)Ended earlyNCT02241785
What this trial is testing

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 47
Not applicableStudy completedNCT04367285
What this trial is testing

Sensor-based Technology for Upper Limb Rehabilitation

Who this might be right for
Multiple Sclerosis
I.R.C.C.S. Fondazione Santa Lucia 35
Early research (Phase 1)Study completedNCT06429085
What this trial is testing

Rex Robot Assisted Rehabilitation to Enhance Balance and Mobility for People With Multiple Sclerosis, Clinical and Biomarker Study - RAPPER IV

Who this might be right for
Multiple Sclerosis
East Kent Hospitals University NHS Foundation Trust 20
Testing effectiveness (Phase 2)Study completedNCT03160898
What this trial is testing

Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 458
Not applicableStudy completedNCT00618267
What this trial is testing

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

Who this might be right for
Multiple Sclerosis
Biogen 100
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Not applicableLooking for participantsNCT04265144
What this trial is testing

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Who this might be right for
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux 500
Not applicableUnknownNCT03321487
What this trial is testing

Blood-Brain Barrier Opening Using MR-Guided Focused Ultrasound in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
InSightec 8
Not applicableStudy completedNCT05177952
What this trial is testing

Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

Who this might be right for
Training StudyMultiple SclerosisBlood Flow Restriction
University of Central Florida 20
Not applicableStudy completedNCT02411838
What this trial is testing

Calorie Restriction in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Washington University School of Medicine 17
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)UnknownNCT04744532
What this trial is testing

IPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Kyoto University 49
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Large-scale testing (Phase 3)Looking for participantsNCT05834855
What this trial is testing

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingDemyelinating Autoimmune Diseases, CNS+3 more
Amsterdam UMC, location VUmc 200
Not applicableLooking for participantsNCT03959163
What this trial is testing

The Validity of the Quick Renal MRI in Pediatric Kidney Disease

Who this might be right for
PyelonephritisPyelonephritis AcuteRenal Sclerosis
University of Wisconsin, Madison 100
Load More Results